DIACOMIT® (stiripentol) Official Brand Website
DIACOMIT (stiripentol) is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam and who are 6 months of age or older and weigh 15 pounds or …
About DIACOMIT
DIACOMIT (stiripentol) is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam and who are 6 months of age or older and weigh 15 pounds or …
DIACOMIT® (stiripentol) Efficacy I HCP Site
DIACOMIT (stiripentol) is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg or …
DIACOMIT® (stiripentol) Dosing I HCP Site
The recommended oral dosage of DIACOMIT is 50 mg/kg/day, divided into two or three doses (i.e., 16.67 mg/kg three times daily or 25 mg/kg two times daily), depending on your patient’s …
DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam who are 6 months of age and older and weighing 7 kg or more .
DIACOMIT® (stiripentol) Access and Affordability I HCP Site
Biocodex believes that those who need DIACOMIT should be able to get it, regardless of their financial status or insurance coverage. There are four patient access programs in place to help …
DIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking clobazam. There are no clinical data to support the …
Starting DIACOMIT® (stiripentol)
DIACOMIT (stiripentol) is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam and who are 6 months of age or older and weigh 15 pounds or …
Resources - DIACOMIT® (stiripentol) and Dravet Syndrome …
DIACOMIT (stiripentol) is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam and who are 6 months of age or older and weigh 15 pounds or …
Prescribing Information - Diacomit
DIACOMIT (stiripentol) is indicated for the treatment of seizures associated with Dravet syndrome in patients taking clobazam and who are 6 months of age or older and weigh 15 pounds or …